Baker Tilly Wealth Management
CVS icon

Baker Tilly Wealth Management’s CVS Health CVS Stock Holding History

Baker Tilly Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$998K Sell
11,644
-491
-4% -$48.1K 0.2% 92
2026
Q2 		$1.26M Sell
12,135
-1,298
-10% -$116K 0.27% 62
2026
Q1 		$965K Buy
13,433
+196
+1% +$15.1K 0.23% 85
2025
Q4 		$1.05M Sell
13,237
-61
-0.5% -$4.81K 0.26% 76
2025
Q3 		$1M Sell
13,298
-270
-2% -$18.5K 0.23% 89
2025
Q2 		$936K Buy
13,568
+471
+4% +$30.9K 0.33% 66
2025
Q1 		$887K Buy
+13,097
New +$784K 0.35% 69
2024
Q4 		– Sell
-4,595
Closed -$289K – 239
2024
Q3 		$289K Sell
4,595
-3,808
-45% -$222K 0.13% 184
2024
Q2 		$496K Sell
8,403
-9,065
-52% -$567K 0.2% 121
2024
Q1 		$1.39M Buy
17,468
+406
+2% +$31K 0.25% 92
2023
Q4 		$1.35M Sell
17,062
-3,030
-15% -$216K 0.22% 104
2023
Q3 		$1.4M Sell
20,092
-940
-4% -$66.6K 0.23% 92
2023
Q2 		$1.45M Buy
21,032
+4,638
+28% +$330K 0.15% 143
2023
Q1 		$1.22M Buy
16,394
+1,471
+10% +$123K 0.14% 170
2022
Q4 		$1.39M Sell
14,923
-390
-3% -$37.6K 0.17% 134
2022
Q3 		$1.46M Buy
15,313
+622
+4% +$61.6K 0.2% 107
2022
Q2 		$1.36M Sell
14,691
-190
-1% -$18.5K 0.18% 123
2022
Q1 		$1.51M Sell
14,881
-584
-4% -$61.4K 0.17% 127
2021
Q4 		$1.6M Buy
15,465
+2,097
+16% +$194K 0.17% 122
2021
Q3 		$1.13M Buy
13,368
+1,809
+16% +$152K 0.15% 142
2021
Q2 		$964K Buy
11,559
+1,325
+13% +$109K 0.16% 152
2021
Q1 		$770K Buy
10,234
+404
+4% +$29.4K 0.16% 165
2020
Q4 		$671K Buy
+9,830
New +$639K 0.21% 113

Other funds holding CVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Baker Tilly Wealth Management's CVS Position: Q3 2026 in Review

Baker Tilly Wealth Management reduced its CVS Health (CVS) stake by 4% in Q3 2026, selling an estimated $48.1K and leaving 11,644 shares worth $998K. The position accounts for 0.2% of the portfolio, ranked #92.

Baker Tilly Wealth Management first reported a position in CVS in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.6M in Q4 2021. 1,215 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Baker Tilly Wealth Management held 11,644 shares of CVS Health worth $998K as of Q3 2026.
  • Baker Tilly Wealth Management sold 491 CVS Health shares in Q3 2026, an estimated $48.1K.
  • CVS Health made up 0.2% of Baker Tilly Wealth Management's portfolio in Q3 2026, its #92 holding.
  • Baker Tilly Wealth Management first reported a position in CVS Health in Q4 2020 and has held it in 23 quarters since.
  • Baker Tilly Wealth Management's CVS Health position peaked at $1.6M in Q4 2021.
  • 1,215 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.